Globus Medical, Inc. Provides Sales Guidance for the Fourth Quarter and Full Year Ending December 31, 2016 and Earnings Guidance for the Full Year of Fiscal 2017
January 11, 2017 at 03:38 am IST
Share
Globus Medical, Inc. provided sales guidance for the fourth quarter and full year ending December 31, 2016 and earnings guidance for the full year of fiscal 2017. The company anticipates fourth quarter 2016 sales of approximately $151.6 million, an increase of 6.3% as reported or 6.6% in constant currency over the fourth quarter 2015.
Full year 2016 estimated sales are expected to be approximately $564.0 million, an increase of 3.5% as reported or 3.8% in constant currency over the prior year.
The company established full year 2017 guidance of $625 million in sales, including $5 million of currency headwinds, and fully diluted earnings per share of $1.27.
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the majority of conditions affecting the spine, including degenerative conditions, deformity, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery (MIS) techniques. It includes traditional fusion implants, such as pedicle screws and rod systems. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
Globus Medical, Inc. Provides Sales Guidance for the Fourth Quarter and Full Year Ending December 31, 2016 and Earnings Guidance for the Full Year of Fiscal 2017
GLOBUS MEDICAL, INC. 
